Skip to main content

* from the date of manufacture
or until solution is clear

Early recognition and prompt treatment of a malignant hyperthermia (MH) crisis are essential for a patient’s survival.1

Be prepared with REVONTO.

Watch a real-life training simulation

Learn how to minimize the risk of MH, recognize warning signs, and find out what to do if a crisis strikes.
Learn About REVONTO Dosing
Ordering Information
ndc vial
  1. Glahn KP, Ellis FR, Halsall PJ, et al. Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group. Br J Anaesth. 2010;105(4):417-420.

Open ISI